Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Marijuana will be the single best investment idea of the next decade: Todd Harrison
http://finance.yahoo.com/blogs/daily-ticker/marijuana-will-be-the-single-best-investment-thesis-of-the-next-decade--minyanville-s-harrison-162358070.html
Yep. Within two days hits 300% from .005 to .0150+
Short Term Target : .05
Mid Term Target : .10
Log term Target : .50
WEED RUNNERS alerted USEI at .005 it's going to .05+ short term
Really Great
Tony Miller, CEO of $USEI plans to be at #Zazzz reveal. Makes sense since his "The Real MCcoy" brand is in talks to be sold out of it. $ERBB
We have two weeks for that.
Great
$DSCR Undervalued MJ Play. Industrial Hemp, finalizing a deal with vaporizers and e-cigs for MJ, 1 billion share reduction, small float, golden cross, up-listing coming soon, doesn't get any better! Check out the latest PR's, only a matter of time until she soars.
Tranzbyte to Unveil its ZaZZZ™ Machine on April 12th in Avon, Colorado
USEI HIT HIGH OF .0155 TODAY from WEED RUNNERS ALERT AT .005 looking for .05+
In next 2 weeks.
SREH expecting jv partner announcement along with company business plan.
Medical Marijuana Inc. Announces Fourth Quarter 2013 Shareholders Report
Date : 03/27/2014 @ 9:00AM
Source : GlobeNewswire Inc.
Stock : Medical Marijuana, Inc. (PC) (MJNA)
Quote : 0.3005 0.0055 (1.86%) @ 9:46AM
Medical Marijuana Inc. Announces Fourth Quarter 2013 Shareholders Report
Tweet Print
Alert
Medical Marijuana, Inc. (PC) (USOTC:MJNA)
Intraday Stock Chart
Today : Thursday 27 March 2014
Click Here for more Medical Marijuana, Inc. (PC) Charts.
Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and industrial hemp industry innovator, today announced the release of its quarterly financial and shareholders report (Post 03/27/2014 - OTC Markets). The Company earned a net income of approximately $5.2 million on gross income of approximately $8.4 million, derived from sales and the final quarterly PhytoSPHERE payment, for the quarter ending December 31, 2013. Below are the Company's fourth quarter 2013 operating and developmental highlights.
Operating highlights for the fourth quarter are as follows:
HempMedsPX
HempMedsPX posted revenues of $1,403,017 in Q4, up from $248,859 in Q3.
The company is in the process of evaluating several potential employees or new hires to run and further develop HempMedsPX.
Hired internal legal and patent consultants, writers, marketing/sales managers, sales staff, distribution staff, a Director of Communications as well as various marketing, website management and product consultants.
As of December, 31 2013, the Company has forty-six (46) team members — including part-time or contracted — within our corporate structure (including subsidiaries).
The Company as experienced significant rapid growth and as such is in the process of securing a warehouse and distribution center as well as new corporate offices to facilitate expansion.
Exhibited products and/or sponsored a variety of trade shows including:
Sept. 30-Oct. 2: Miami Wholesale Expo, Miami
Oct. 5-6: The Ultimate Women's Expo, San Francisco
Oct. 10-20: Ohio Rights Group Tour
Oct. 19-20: The Ultimate Women's Expo, Phoenix
Oct. 21-23: 2013 ISPA Conference & Expo, Las Vegas
Oct. 22-24: Champs, Denver
Oct. 23-26: Drug Policy Alliance (DPA), Denver
Oct. 26-27: The Ultimate Women's Expo, Los Angeles
Nov. 6-8: 2nd Annual National Marijuana Business Conference & Expo, Seattle
Nov. 9-10: Green Festival, San Francisco
Nov. 14-15: Supply Side West, Las Vegas
Nov. 15-17: Michigan Medical Marijuana Trade Show
Dec. 3: The High Times Medical Cannabis Cup, Amsterdam
Dec. 5-7: SOHO Natural Products Expo, Orlando
Dec. 12-15: 21st Annual World Congress on Anti-Aging, Regenerative & Aesthetic Medicine
Represented the winner of the world-renowned 2013 High Times Cannabis Cup (Amsterdam) contest for Highest (hemp) CBD Concentrate.
CanChew Biotechnologies
Sales of CanChew gum for Q4 were $57,620, up from $33,887 in Q3.
MedChewRX, a cannabis-based THC/CBD pharmaceutical drug, is still scheduled to move forward with its clinical trials in Europe in 2014, with the overall clinical development taking three to five years.
PhytoSPHERE Systems
PhytoSPHERE received final payment of $6,500,000 payment from CannaVest which was paid in 1,083,333 shares of CannaVest common stock. Hemp Deposit Distribution Corp. (HDDC) has deferred their 20% payment to support expansion to enhance their investment.
Red Dice Holdings
Red Dice Holdings reported total income for Q4 of $433,129, up from $321,671 in Q3.
Wellness Managed Services
The Company finalized a transaction that will allow for staffing and compliance management service contracts to be developed. The company will initially focus on Colorado and Arizona.
A statement from MJNA.
Medical Marijuana, Inc is extremely pleased with Q4 performance which has exceeded expectations in sales and awareness of the benefits of CBD-rich hemp oil products. Due to rapidly expanding growth, the Company is in the process of securing additional office space to relocate the corporate office and obtain a larger warehousing distribution center. It is anticipated that sales and customer service will remain at the existing facility.
To reach a wider audience, HempMedsPX chose to participate in cannabis industry, personal care and spa, international reform policy, health and wellness, and natural products events to showcase their diverse hemp CBD product offerings. The Company's efforts have been well received and resulted in thousands of business-to-business and business-to-consumer impressions, distribution contacts, and sales leads. There was a significant increase in sales as a direct result of participating in an aggressive exhibit schedule that began in Q3 2013 and continued through Q4 2013.
National community outreach programs were also launched in an effort to support families facing epilepsy, autism, and other debilitating health challenges. Significant donations were made to the Hope4Harper 5K Run and the San Diego Epilepsy Foundation. HempMedsPX will continue and expand its charitable outreach efforts in 2014.
In Q4, HempMedsPX was awarded the Doctor Trusted seal for its e-commerce websites — a significant step toward broader mainstream acceptance of hemp-based CBD products and the Company in general.
2013 ended with a surge in sales and interest in CBD-rich hemp oil products. We extend our deepest gratitude for the continued support of our shareholders, without whom none of this expansion would have been possible. We are excited about future endeavors and about the future of the cannabis industry in general.
As legalization spreads throughout the United States and the world, we are ready to address the public demand for quality hemp-based CBD products and service solutions. We invite shareholders and the general public to interact with us via the MJNA Facebook page and the HempMedsPX Facebook page, and for real time updates and information on company activities and announcements. We encourage anyone interested in additional details about Q4 2013 to refer to Post 03/27/2014 - OTC Markets.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the Company's website at: www.MedicalMarijuanaInc.com
About CannaVest Corp.
CannaVest Corp. is in the business of investing and developing hemp-based cannabinoid companies. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells — to third parties — raw product acquired by CannaVest Corp. pursuant to the company's international supply relationships. CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant, and CBD is derived from hemp stalk and seed. Additional information is available from OTCMarkets.com or by visiting CannaVest.com.
About HempMedsPX
HempMedsPX™ offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX™ is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp and Medical Marijuana, Inc. In addition to handling sales and distribution, HempMedsPX™ is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About CanChew Biotechnologies
CanChew Biotechnologies focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products as well as food and nutraceutical products for general well-being.
The company is focused on the R&D and execution of their clinical development plan and potential out-licensing of their technology. Clinical development focuses on the R&D of the formulation, production and the development of chewing gum-based products for the treatment of conditions like pain, nausea and vomiting, anorexia, spasticity and various other medical issues. For more information on the company, visit CanChewBiotech.com.
About PhytoSPHERE Systems
PhytoSPHERE Systems is a global phytocannabinoid biotechnology company based in San Diego, California with an exclusive license for use by CannaVest Corp. The company utilizes advanced cultivation methods and state-of-the-art processing technology leading to development of pharmaceutical, nutraceutical and food products.
PhytoSPHERE Systems, the manufacturer of the CBD-rich hemp oil used in Real Scientific Hemp Oil (RSHO), has developed special cultivars (similar to "strains") that produce hemp that is especially rich in CBD, making it possible for PhytoSPHERE to offer all-natural products with high concentrations of hemp-based CBD. For more information, visit: PhytoSPHERESystems.com
About Wellness Managed Services
Wellness Managed Services provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics throughout North America. The services offered range from practice management to product distribution. Our mission is to provide a comprehensive array of clinically supporting health and wellness products and services which will attract patients while providing for a fully operational, profitable enterprise. We seek to provide facilities and patients alike with the latest in quality products and support services that will serve the health and wellness community. For more info, click here.
About Red Dice Holdings
Red Dice Holdings, LLC ("Red Dice") is the owner of the Dixie Brand of products including, Dixie Botanicals. The company has over 70 unique consumer products and is one of the most recognizable cannabis and hemp brands in the world. For more information on Red Dice Holdings, click here.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
LEGAL DISCLOSURE
Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT: For further information, please contact:
Investor relations contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
info@smallcapvoice.com
Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
USEI next big RUNNER $$$$$$$$$
USEI : Miller further stated, "We now have the capital, and we have been in touch with farmers in Colorado and seed providers. It is our hope to farm, or partner with farmers to grow hemp in Colorado; once legally permissible. We are also looking at other ventures in Colorado, that are related to growing technologies and marketing consumable products."
USEI : 11 reasons why you should invest in the biodiesel industry
1. Jump in on a growing market: The U.S. biodiesel industry is poised for its most profitable, successful year yet in 2013 with expected record-breaking production volumes thanks in part to the increased federal biomass-based diesel requirement of 1.28 billion gallons (28 percent higher than 2012), the $1 per gallon tax credit and rebounding D4 RIN prices. In addition, favorable blend economics indicate that obligated parties under the renewable fuel standard (RFS2) will find it economically advantageous* to blend U.S. biodiesel over Brazilian sugarcane ethanol to meet their advanced biofuel obligations (2.75 billion ethanol-equivalent gallons), over and above the biomass-based diesel volume requirements, suggesting the possibility of domestic biodiesel production significantly exceeding 1.28 billion gallons. *farmdoc daily
2. Sustainable 10-year growth plan: IHS Global Insight conducted a modeling report for the National Biodiesel Board to help guide EPA with its yearly biodiesel RVO under RFS2 and, in the modeling report, the group determined that there will be enough feedstock available to reach 3.3 billion gallons of U.S. biodiesel production by 2022. Read article
3. The National Biodiesel Board unveiled a new industry target in February 2013, named 10×22, an aggressive but achievable goal that calls for biodiesel to make up 10 percent of the U.S. diesel fuel supply by 2022. Read article
4. Engine makers support biodiesel, why not you? All major OEMs producing diesel vehicles for the U.S. market support at least B5 and lower blends and 79 percent of U.S. manufacturers now support B20 or higher biodiesel blends in at least some of their equipment. Source: NBB OEM support document, Sept. 2012
5. No blend wall here: While the ethanol industry struggles with hitting its blend wall, biodiesel penetration in the 2012 U.S. diesel fuel supply was only 1.9 percent. Given that all major OEMs support B5, achieving a 5 percent biodiesel penetration rate would mean nearly 3 billion gallons of biodiesel production (almost three times greater than 2012 production volumes). Moreover, nearly all the biodiesel used in the U.S. today is consumed by heavy-duty applications, a growing number of which support B20. To reach 20 percent penetration, the U.S. would need to produce 11.5 billion gallons of biodiesel, 10 times more than produced last year. Read article
6. Global ethanol and biodiesel consumption combined will reach 135 billion gallons by 2018. Source: Global Industry Analysts Inc.
7. Biodiesel quality continues to improve: The latest NREL quality survey results announced February 2013 at the National Biodiesel Conference show a record 97 percent of the biodiesel on the market today is within ASTM D6751 specifications. Read article
8. 68 percent of U.S. and Canadian biodiesel productive capacity is BQ-9000-certified, meaning strict quality controls are in place-of the approximately 3 billion gallons of productive capacity in the U.S. and Canada, 1.84 billion gallons is BQ-9000-certified versus 1.24 billion gallons that is not. Source: 2013 Biodiesel Plant Map and the BQ-9000 site of certified producers
9. Greenhouse gas emissions will continue to tighten globally, and EPA has determined that biodiesel from waste achieves more than 80 percent GHG reduction compared to the fossil diesel baseline, while biodiesel made from soybean oil achieves greater than 50 percent GHG reductions. Source: EPA
10. Assurance in the market: Obligated parties, third-party quality assurance plan (QAP) providers, the biodiesel industry and government have worked together to restructure the RIN program to provide more security against potential fraud. A proposed QAP rule was issued in January and a final rule is expected midyear. The proposal offers obligated parties an affirmative defense against civil liabilities from buying, trading or retiring bad RINs, and includes one option that also relieves obligated parties from paying for the replacement of any invalid RINs. Source: U.S. EPA
11. Supporting biodiesel supports economic growth: The biodiesel industry spent an estimated $4.3 billion to produce 1 billion gallons of biodiesel in 2012, without the $1 per gallon federal tax credit in place all year. The biodiesel industry supported approximately 64,000 jobs in 2012, once again without the $1 per gallon tax credit. With the credit, it would have supported another 19,200, totaling more than 83,000 jobs. Source: NBB Fueling Action
http://investorshub.advfn.com/US-Energy-Initiatives-Corp-USEI-5982/
USEI has two major business division : Energy and Marijuana
Here is the link about Energy which will be alternative of fuel in future.
FSPM trace the bottom today under $5. Expecting Financials and more updates.
USEI : Alerted .005 on 3.24.2014
Badali Member Level Monday, 03/24/14 02:05:59 PM
Re: None
Post # of 12351
I believe .005 is going soon.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=99358401
Badali, everyone is jumping on GLCO don't miss the boat.
FSPM fillings are just out today.
http://www.otcmarkets.com/financialReportViewer?symbol=FSPM&id=115419
Do we have news on the way?
FSPM will be $10 Right now trading $1.39
GRPS may be a P&D but should be good for next few days
Not sure. I am thinking about RIGH. I believe it will make a huge run. Now trading between 3 and 4 from a last couple of days.
Do u have any idea.
What's going on with GRPS?
Great Board badali, like to see you here: http://investorshub.advfn.com/Bank-on-Weed-27761/
I'm looking to go in heavy on the WEED stocks this week. Which one can I count on to pop in next
two days.
RIGH IS GOING TO BIG. I CAN SAY .001 IS VERY SOON.
LATF is going huge next week.
ERBB,LATF and RIGH will BOOM very soon.
LATF is on the way to reach 52 weeks high in coming days.
Waiting for ERBB updates regarding 21 Machine
ERBB retrace back and hit high early. Looking another big run here in coming days
LATF has huge volume today. Tomorrow will be gap and big run. Earnings are due.
MJNA MOVING BACK AND AND REVERSE SPLIT IMMINENT
RAYS was alerted by multiple groups so its not my play. Tons of groups jumped in the bandwagon and pumped it up and I myself chased it up. Did not expect such a drop like that so fast thought it would repeat TCPS to an extent at least.
GM, would you agree that RAYS is one of your (and PSG´s) - admittedly seldom - wimps ... at least for those who had missed its first and so far single run? Proof for that theory: Zero posts/updates neither from PSG nor from you since some time ... that´s telling IMO ... hoped it´d recover ...
Looking forward to get a reply from you, yet again ... TIA
MYEC 0047~~>> 52 week high @ $1 dollar per share! HUGE Comeback on the way guys. Multiple big news pending and so much more!
You pulled the truth. Tsk tsk
Ok. I can see it in the medical space. Looks like medbox has this one and sued autospence? Still don't see it for the casual user...and for most medical patients. Too invasive with the biometrics thing and too liberal for society in the public square.
That aside, erbb has a long ways to go to get out of pump and dump zone. Hope they can do it and are able to legally produce a great organic product.
Followers
|
14
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
233
|
Created
|
12/16/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |